Pediatric Extraspinal Sacrococcygeal Ependymoma: A Structured Narrative Review of Published Cases and Diagnostic Challenges
Cancers · 26.10.2026 · 18 (21) · 3459
DOI: 10.3390/cancers18213459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.10.2026. Verfasst von Eleonora Nativi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Surgery Unit, Maternity and Children Department, University of Pisa, 56126 Pisa, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extraspinal sacrococcygeal ependymoma is a rare pediatric neoplasm that frequently presents as a superficial sacrococcygeal mass, closely resembling benign conditions such as pilonidal disease or cysts. As a result, preoperative diagnosis is often incorrect, leading to incomplete surgical excision and delayed clinical management. We conducted a comprehensive descriptive review of the pediatric literature to examine its epidemiology, clinical presentation, diagnostic challenges, pathological characteristics, treatment strategies, and outcomes. Materials and Methods: A structured literature search of PubMed, Scopus, and Web of Science from database inception to June 2026 was conducted. Only English studies reporting histologically confirmed extraspinal sacrococcygeal ependymoma in patients younger than 18 years were included.
Discussion
Histologically, the vast majority of extraspinal sacrococcygeal ependymomas are of the myxopapillary subtype. Historically classified as grade 1 tumors by the World Health Organization (WHO), they were reclassified as WHO grade 2 in the 2021 WHO Classification of Tumors of the Central Nervous System. This change reflects the rising recognition of the clinically relevant risk of local recurrence and metastatic dissemination of these tumors, despite a relatively indolent growth pattern. Because extraspinal sacrococcygeal ependymomas may recur many years after initial treatment and occasionally metastasize to lymph nodes, lungs, liver, bone, or other distant sites, they should not be considered entirely benign lesions. Then, their management requires an oncological approach despite their often innocuous clinical appearance.
Conclusions
Given the risk of delayed recurrence and distant metastasis, long-term follow-up is mandatory. Increased awareness of this singular entity, appropriate preoperative imaging of atypical sacrococcygeal lesions, and multidisciplinary management are essential to optimize outcomes. Future multicenter collaborative studies are needed to establish evidence-based recommendations for diagnosis, treatment, and surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Surgery Unit, Maternity and Children Department, University of Pisa, 56126 Pisa, Italy.
- Division of Pediatric Surgery, Department of Medical Sciences, Surgical Sciences and Neurosciences, University of Siena, 53100 Siena, Italy.
- Histopathology Department, Pisa University Hospital, 56126 Pisa, Italy.
ORCID-Profile: Angela Pucci
Zitieren
APA
Nativi, E., Virgone, V. M., Bassan, E., Stefani, B., Cordola, C., Pucci, A., & Ghionzoli, M. (2026). Pediatric Extraspinal Sacrococcygeal Ependymoma: A Structured Narrative Review of Published Cases and Diagnostic Challenges. Cancers, 18(21), 3459. https://doi.org/10.3390/cancers18213459
Vancouver
Nativi E, Virgone VM, Bassan E, Stefani B, Cordola C, Pucci A, et al. Pediatric Extraspinal Sacrococcygeal Ependymoma: A Structured Narrative Review of Published Cases and Diagnostic Challenges. Cancers. 2026;18(21):3459. doi:10.3390/cancers18213459
BibTeX
@article{Nativi2026,
author = {Nativi, Eleonora and Virgone, Vittorio Maria and Bassan, Elisa and Stefani, Bianca and Cordola, Chiara and Pucci, Angela and Ghionzoli, Marco},
title = {Pediatric Extraspinal Sacrococcygeal Ependymoma: A Structured Narrative Review of Published Cases and Diagnostic Challenges},
journal = {Cancers},
year = {2026},
volume = {18},
number = {21},
pages = {3459},
doi = {10.3390/cancers18213459}
}
EUVIMED